The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer

The tyrosine kinase receptor A (NTRK1/TrkA) is increasingly regarded as a therapeutic target in oncology. In breast cancer, TrkA contributes to metastasis but the clinicopathological significance remains unclear. In this study, TrkA expression was assessed via immunohistochemistry of 158 invasive du...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomolecules
Asıl Yazarlar: Griffin, Nathan, Marsland, Mark, Roselli, Severine, Oldmeadow, Christopher, Attia, John, Walker, Marjorie M., Hondermarck, Hubert, Faulkner, Sam
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564775/
https://ncbi.nlm.nih.gov/pubmed/32957504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10091329
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller